刚果基桑加尼孕妇疟疾预防:甲氟喹与磺胺多辛-乙胺嘧啶随机临床试验
在疟疾高传播且磺胺多辛-乙胺嘧啶耐药的刚果基桑加尼,单盲随机试验比较甲氟喹分次随餐与磺胺多辛-乙胺嘧啶间歇性预防治疗孕妇的效果与耐受性。甲氟喹未显著增加副作用,并显著降低胎盘疟疾、母体外周血症和低出生体重风险。
要点
- 甲氟喹分次随餐方案较磺胺多辛-乙胺嘧啶显著降低胎盘疟疾风险(RR 0.4315)。
- 甲氟喹显著降低母体外周血症风险(RR 0.4397)。
- 甲氟喹显著降低低出生体重风险(RR 0.4708)。
核心结论
- 甲氟喹分次随餐方案在保持疗效的同时,耐受性较磺胺多辛-乙胺嘧啶有所提高。
- 甲氟喹间歇性预防治疗可降低胎盘疟疾、母体外周血症和低出生体重风险。
- 甲氟喹可作为孕妇间歇性预防治疗的良好替代方案。
研究设计与样本
- 比较两种孕妇间歇性预防治疗方案:4剂磺胺多辛-乙胺嘧啶 vs 2剂甲氟喹分次随餐。
主要发现
- 甲氟喹组与磺胺多辛-乙胺嘧啶组主要副作用无统计学差异(Fisher精确检验=0.5014)。
- 甲氟喹显著降低胎盘疟疾风险(RR 0.4315,95%CI 0.2201-0.8460)。
- 甲氟喹显著降低母体外周血症风险(RR 0.4397,95%CI 0.2377-0.8132)。
- 甲氟喹显著降低低出生体重风险(RR 0.4708,95%CI 0.2455-0.9029)。
临床怎么用
- 在磺胺多辛-乙胺嘧啶耐药的疟疾高传播区,孕妇间歇性预防治疗可考虑甲氟喹分次随餐方案。
- 甲氟喹分次随餐给药可能提高耐受性,但需结合当地耐药情况和患者个体因素评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Kisangani is an area with intense malaria transmission and sulfadoxine-pyrimethamine resistance. Alternative antimalaria prophylaxis medication and protocols are needed, particularly with pregnant individuals. In this study, we compare the tolerance and effectiveness of mefloquine regimen as a split dose with a meal vs. sulfadoxine-pyrimethamine for the intermittent preventive treatment in pregnant individuals in Kisangani. METHODS: This study was conducted from 15 May to 30 November 2019 as a single-blind, randomized clinical trial comparing 2 regimens of intermittent preventive treatment during pregnancy. The first regimen consisted of 4 doses of sulfadoxine-pyrimethamine, and the second of 2 doses of mefloquine taken as a split dose with meal. RESULTS: The occurrence of major or minor side-effects among patients treated with mefloquine and those treated with sulfadoxine-pyrimethamine were not statistically significant (major side effects: Fisher exact = 0.5014; minor side effects: P = .0961). Intermittent preventive treatment using mefloquine significantly reduced the risk of placental malaria (risk ratio [RR]: 0.4315, 95% confidence interval [CI]: 0.2201-0.8460), maternal peripheral parasitaemia (RR: 0.4397, 95% CI: 0.2377-0.8132) and low birth weight (RR: 0.4708, 95% CI: 0.2455-0.9029). CONCLUSION: Splitting dose and intake with a meal increased mefloquine tolerability while keeping its efficacy higher compared to sulfadoxine-pyrimethamine. Intermittent preventive treatment during pregnancy using mefloquine reduces the risk of placental malaria, maternal peripheral parasitaemia and low birth weight, compared to sulfadoxine-pyrimethamine. Thus, mefloquine is a good alternative to intermittent preventive treatment in pregnancy.
引用
- Labama Otuli N, Marini Djang'eing'a R, Losimba Likwela J, et al. Efficacy and safety of malarial prophylaxis with mefloquine during pregnancy in Kisangani, Democratic Republic of Congo: A randomized clinical trial. Br J Clin Pharmacol. 2021. PMID: 33398890. doi:10.1111/bcp.14720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。